Z Wang
Shandong University of Traditional Chinese Medicine
ORCID: 0000-0003-1513-3511Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 5 papers. Top paper: “A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations”.
Q Zhou, H H Yan, X C Zhang, H J Chen, H Y Tu +10 more
Franziska Pohl, Xavier Anderson, Shoshana C. Williams, Imienreluefe Gregory Adodo, Patrick J. Hunt +10 more
Yun Chen, Zhangying Cai, Gyu Seong Heo, Carla M. Yuede, Z Wang +21 more
Franziska Pohl, Xavier Anderson, Shoshana C. Williams, Imienreluefe Gregory Adodo, Patrick J. Hunt +10 more
Joaquim Mansano Garcia, Jiao Li, Z Wang, Renate M. Hoogeveen, Donna L. White +5 more